NO20071833L - Anvendelse av en autiaterotrombotisk forbindelse for a oppna medikamenter tiltenkt for behandlingen av vaskulaere lidelser - Google Patents

Anvendelse av en autiaterotrombotisk forbindelse for a oppna medikamenter tiltenkt for behandlingen av vaskulaere lidelser

Info

Publication number
NO20071833L
NO20071833L NO20071833A NO20071833A NO20071833L NO 20071833 L NO20071833 L NO 20071833L NO 20071833 A NO20071833 A NO 20071833A NO 20071833 A NO20071833 A NO 20071833A NO 20071833 L NO20071833 L NO 20071833L
Authority
NO
Norway
Prior art keywords
treatment
vascular disorders
autiaterotrombotic
taking
compound
Prior art date
Application number
NO20071833A
Other languages
English (en)
Inventor
Gilbert Lavielle
Tony Verbeuren
Laurence Lerond
Marie-Dominique Fratacci
Agnes De Cordoue
Alain Ruoin
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20071833L publication Critical patent/NO20071833L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse vedrører anvendelsen av 3-{6-[(4-klorfenylsulfonyl)amino]-2-metyl-5,6,7,8-tetrahydronaft-1-yl}propionsyre, en spesifikk antagonist av TP-reseptorene, for å oppnå medikamenter tiltenkt for behandlingen av vaskulære lidelser i pasienter som har hatt et tidligere cerebralt vaskulært tilfelle, særlig for å redusere cerebrovaskulære og kardiovaskulære hendelser i pasienter som har hatt et tidligere cerebralt iskemisk tilfelle (CIA) eller forbigående iskemisk anfall (TIA).
NO20071833A 2006-04-07 2007-04-10 Anvendelse av en autiaterotrombotisk forbindelse for a oppna medikamenter tiltenkt for behandlingen av vaskulaere lidelser NO20071833L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603082A FR2899473B1 (fr) 2006-04-07 2006-04-07 Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires

Publications (1)

Publication Number Publication Date
NO20071833L true NO20071833L (no) 2007-10-08

Family

ID=37084627

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071833A NO20071833L (no) 2006-04-07 2007-04-10 Anvendelse av en autiaterotrombotisk forbindelse for a oppna medikamenter tiltenkt for behandlingen av vaskulaere lidelser

Country Status (40)

Country Link
US (1) US20070238785A1 (no)
EP (2) EP1842537B1 (no)
JP (1) JP2009532447A (no)
KR (2) KR20070100658A (no)
CN (2) CN101693025A (no)
AP (1) AP2007003952A0 (no)
AR (1) AR060288A1 (no)
AT (1) ATE452633T1 (no)
AU (1) AU2007201525A1 (no)
BR (1) BRPI0701597A (no)
CA (1) CA2582394A1 (no)
CO (1) CO5820217A1 (no)
CR (1) CR9020A (no)
CY (1) CY1109793T1 (no)
DE (1) DE602007003880D1 (no)
DK (1) DK1842537T3 (no)
EA (1) EA013874B1 (no)
ES (1) ES2338600T3 (no)
FR (1) FR2899473B1 (no)
GE (1) GEP20094782B (no)
GT (1) GT200700029A (no)
HR (1) HRP20100091T1 (no)
IL (1) IL182406A0 (no)
MA (1) MA28988B1 (no)
MX (1) MX2007004108A (no)
NI (1) NI200700083A (no)
NO (1) NO20071833L (no)
NZ (1) NZ554348A (no)
PE (1) PE20071147A1 (no)
PL (1) PL1842537T3 (no)
PT (1) PT1842537E (no)
RS (1) RS51207B (no)
SG (1) SG136882A1 (no)
SI (1) SI1842537T1 (no)
SV (1) SV2008003053A (no)
TN (1) TNSN07117A1 (no)
TW (1) TW200808306A (no)
UY (1) UY30263A1 (no)
WO (1) WO2007116138A1 (no)
ZA (1) ZA200702866B (no)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102862D0 (en) * 1991-02-11 1991-03-27 Erba Carlo Spa N-imidazolyl derivatives of substituted or alkoxymino tetrahydronaphthalenes and chromans
RU2120292C1 (ru) * 1992-07-22 1998-10-20 Российско-германское акционерное общество закрытого типа "УТИЛЕКС" Способ лечения мозговых сосудистых кризов
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DE4343776A1 (de) * 1993-12-17 1995-06-22 Schering Ag Cyclopentanonderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
JPH08119936A (ja) * 1994-10-18 1996-05-14 Fujisawa Pharmaceut Co Ltd 複素環式誘導体
FR2805261A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2857593B1 (fr) * 2003-07-18 2005-10-14 Servier Lab Composition pharmaceutique orodispersible d'un compose antithrombotique
FR2860436B1 (fr) * 2003-10-03 2006-01-20 Servier Lab Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire

Also Published As

Publication number Publication date
FR2899473A1 (fr) 2007-10-12
AR060288A1 (es) 2008-06-04
TNSN07117A1 (fr) 2008-06-02
ES2338600T3 (es) 2010-05-10
AP2007003952A0 (en) 2007-04-30
HRP20100091T1 (hr) 2010-04-30
GEP20094782B (en) 2009-09-25
KR20090086500A (ko) 2009-08-13
CR9020A (es) 2008-09-23
CO5820217A1 (es) 2007-11-30
PE20071147A1 (es) 2007-12-22
SV2008003053A (es) 2009-12-02
EA013874B1 (ru) 2010-08-30
UY30263A1 (es) 2007-05-31
BRPI0701597A (pt) 2007-12-11
JP2009532447A (ja) 2009-09-10
CY1109793T1 (el) 2014-09-10
EP1842537B1 (fr) 2009-12-23
CA2582394A1 (fr) 2007-10-07
EA200700573A3 (ru) 2007-12-28
MA28988B1 (fr) 2007-11-01
SG136882A1 (en) 2007-11-29
KR20070100658A (ko) 2007-10-11
ATE452633T1 (de) 2010-01-15
NZ554348A (en) 2008-09-26
RS51207B (sr) 2010-12-31
EP1842537A1 (fr) 2007-10-10
GT200700029A (es) 2007-10-31
PT1842537E (pt) 2010-01-15
DK1842537T3 (da) 2010-04-12
FR2899473B1 (fr) 2008-06-13
EP2105132A1 (fr) 2009-09-30
EA200700573A2 (ru) 2007-10-26
AU2007201525A1 (en) 2007-10-25
CN101049292A (zh) 2007-10-10
IL182406A0 (en) 2008-01-20
MX2007004108A (es) 2009-02-16
NI200700083A (es) 2008-06-09
TW200808306A (en) 2008-02-16
US20070238785A1 (en) 2007-10-11
DE602007003880D1 (de) 2010-02-04
ZA200702866B (en) 2008-07-30
CN101693025A (zh) 2010-04-14
SI1842537T1 (sl) 2010-03-31
WO2007116138A1 (fr) 2007-10-18
PL1842537T3 (pl) 2010-06-30

Similar Documents

Publication Publication Date Title
EA201101187A1 (ru) Антидиабетические лекарственные средства, содержащие ингибитор dpp-4 (линаглиптин) необязательно в комбинации с другими антидиабетическими средствами
WO2006020598A3 (en) Amido compounds and their use as pharmaceuticals
BRPI0512535A (pt) compostos de piperidinas n-substituìdas, suas composições e métodos de modulações
WO2007038138A3 (en) Amido compounds and their use as pharmaceuticals
MA29799B1 (fr) Administration d'inhibiteurs de dipeptidyl peptidase
BR0308290A (pt) Tratamento e prevenção de distúrbios inflamatórios
WO2006002361A3 (en) 2-methylpropanamides and their use as pharmaceuticals
WO2007106317A3 (en) Pharmaceutical combinations of hcv-protease and -ires inhibitors
WO2008097835A3 (en) Compositions and methods for the treatment of metabolic disorders
WO2005070462A3 (en) Compositions comprising (s)-amlodipine and an angiotensin receptor blocker and methods of their use
WO2006012227A3 (en) Amido compounds and their use as pharmaceuticals
NO20074943L (no) Roflumilast for behandlingen av diabetes mellitus
EP2508178A3 (en) Use of nutritional compositions for preventing disorders
NO20065442L (no) Amidoforbindelser og deres anvendelse som legemidler
NO20070372L (no) Amidoforbindelser og anvendelse derav som farmasoytiske preparater
WO2007127505A3 (en) Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
WO2008003049A3 (en) Distinguishing different drug effects from the electroencephalogram
WO2008039245A3 (en) Assessment of the effects of topical administration of chemodenervating pharmaceuticals
NO20091838L (no) 2-aminokarbonyl-pyridinderivater
WO2008045564A8 (en) Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
NO20073403L (no) Anvendelse av atazanavir til forbedring av farmakokinetikken til legemidler metabolisert av UGT1A1
MY142804A (en) Nk1 antagonists
BRPI0512379A (pt) composições farmacêuticas compreendendo inibidores de nep, inibidores do sistema de produção de endotelina endógena e antagonista do receptor at1
MX2007004976A (es) Antagonistas de receptor m1 y/o m3 en combinacion con otros compuestos activos para tratar trastornos respiratorios.
WO2008032222A3 (en) Treatment of vertigo with acetyl-l-leucine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application